Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 18 Source: Estimated
- €514.4 million turnover
- 400 employees
-
31st Dec 17 Source: Estimated
- €321.6 million turnover
- 300 employees
- 4 more years available »
Ranking
By Turnover
(€514.4 million)- 152nd in Top Companies
- 22nd in Health
- 20th in Pharma
By Employees
(400)- 407th in Top Companies
- 64th in Health
- 41st in Pharma
- 400
- €514.4 million
Employees
- Shane Doyle Senior vice president
Latest News
- 4:00am Dublin City Council plans to license sandwich boards criticised by small businesses
- 2:00am Irish farmers who want to build solar projects left frustrated as Government drags its heels
- Aug 19 Banking bodies consider shorter trading day to attract more women
- Aug 19 Global markets rise on hopes for easing of trade wars
- Aug 19 Hewlett Packard Enterprise’s Irish unit made loss of €16m last year